It is necessary to search for biomarkers that can predict the efficacy of NDV, such as pre-existing antibody titers, tumor viral receptor expression levels, IFN signaling pathway status, immune cell infiltration, post-treatment viral replication in peripheral blood, and cytokine dynamics. Here, IFNA1 is linked to neoplasm.